Skip to main content

Psoriatic arthritis

    Virtual EULAR 2020 Round Up
    In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include: SELECT-CHOICE study. ABA vs. UPA in…
    These were my top abstracts from Thursday, 4th of June at EULAR 2020: Voclosporin Effective in Lupus Nephritis (OP0277). Voclosporin is a calcineurin inhibitor that has performed well in an…
    These were my top abstracts from Thursday, 4th of June at EULAR 2020. TORTUGA Study (THU0377): Filgotinib in active axial spondyloarthritis patients.  TORTUGA enrolled 116 patients with AxSpA…
    Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial…
    Imaging and Remission Axial Spondyloarthritis

    Dr. Olga Petryna from EULAR2020 Virtual Conference

    OP0079 - what MRI findings are most predictive in AxSpa

    OP0314 - Drug free remission in AxSpA

    RT @uptoTate: Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before
    3 years 10 months ago
    Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before or during pregnancy. Few on TNFi were continued on tx during pregnancy. #EULAR2020 @RheumNow https://t.co/t7B6pASeWQ https://t.co/BwU6RF5Qkn
    RT @uptoTate: Sustained clinical response shown over the 10 yrs of this German study in r-axSpA and nr-axSpA pts treated
    3 years 10 months ago
    Sustained clinical response shown over the 10 yrs of this German study in r-axSpA and nr-axSpA pts treated with ETN. No new safety signals. Abstract #AB0660 #EULAR2020 @RheumNow https://t.co/KCMDyzHaSr https://t.co/yFSTgWqzBQ
    RT @uptoTate: Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 pat
    3 years 10 months ago
    Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 patients within the first 5 months. New-onset MEM is also observed in up to 15% of patients with IBD treated with VDZ. #EULAR2020 @RheumNow https://t.co/ZVjZC7hvxs https://t.co/d1RT3GzB2b
    RT @DrPetryna: #EULAR2020 #op0225 sub study of OPAL Balance: withdrawal of MTxdoes not negatively impact Tofa efficacy i
    3 years 10 months ago
    #EULAR2020 #op0225 sub study of OPAL Balance: withdrawal of MTxdoes not negatively impact Tofa efficacy in PsA. At 6 mo deltaPASDAS 0.229 (0.079) for tofa mono & 0.q138 (0.081) for tofa+mtx. LFT elevation more common in combination arm @RheumNow https://t.co/NO1agViScD